Updated on: September 3, 2026 by John Ingham
Key Points
- MGM-15 is a synthetic or semi-synthetic compound related to 7-OH chemistry, associated with opioid-like effects, and should not be confused with traditional kratom leaf.
- Products may have uncertain strength, ingredients, and labeling, creating risks of rapid tolerance, dependence, withdrawal, sedation, and overdose-especially with other depressants.
- How Brooks helps: Brooks treats MGM-15 and other kratom-derived product dependence with individualized stabilization, residential care, and long-term relapse-prevention support.
MGM-15 is starting to show up in conversations around kratom, 7-OH, smoke shop products, and new opioid-like substances. Some people may see it marketed as “MGM,” “DHM,” or a stronger kratom-style product. That can make it sound like a normal supplement, but MGM-15 is not the same thing as plain kratom leaf.
MGM-15, also known as dihydro-7-hydroxymitragynine, is a synthetic or semi-synthetic derivative related to 7-OH chemistry. It does not appear to be a naturally occurring kratom leaf alkaloid.
For people in recovery, this matters. A product does not have to be called heroin, oxycodone, or fentanyl to affect the opioid system. Some newer substances are sold in legal gray areas before most people understand what they are.
At Brooks Healing Center, we believe people deserve clear information before a substance becomes a crisis.
What Is MGM-15?
MGM-15 is also known as dihydro-7-hydroxymitragynine. It is a synthetic or semi-synthetic derivative related to 7-OH chemistry and does not appear to be a naturally occurring kratom leaf alkaloid.
That sounds technical, so here is the simple version.
Kratom comes from a plant. The plant contains natural chemicals called alkaloids. Two of the best-known kratom alkaloids are mitragynine and 7-OH. MGM-15 is not simply ground kratom leaf. It is a chemically altered compound connected to the same family of kratom alkaloids.
This is why MGM-15 should not be treated like regular kratom tea, powder, or capsules. It may come from kratom chemistry, but it appears to act more like a potent opioid-type substance.
Why MGM-15 Is Raising Concern
The main concern is not just that MGM-15 is new. The concern is that it appears to act strongly on opioid receptors while having very limited human safety data.
Opioid receptors are the same brain and body systems affected by substances like morphine, oxycodone, heroin, and fentanyl. These receptors are involved in pain relief, pleasure, sedation, breathing, dependence, and withdrawal.
Researchers developed MGM-15 and related compounds while studying opioid receptor activity and possible pain treatment pathways. In animal and laboratory studies, MGM-15 and related compounds showed opioid receptor activity. Another related compound, MGM-16, showed even higher potency in certain tests, but MGM-15 itself remains part of this same opioid-focused research space.
The concern is simple: if a substance works strongly on opioid receptors, it may also carry opioid-like risks.
MGM-15 Is Not Regular Kratom
Many people hear “kratom-derived” and assume the risk is similar to kratom leaf. That is not a safe assumption.
Plain kratom leaf contains a mix of alkaloids in natural amounts. Concentrated 7-OH products and semi-synthetic compounds like MGM-15 can be much stronger and more targeted. The FDA has warned consumers to avoid products containing 7-OH when it is added or enhanced because these products may be dangerous and are often sold in forms like tablets, gummies, drinks, and supplements.
MGM-15 fits into a broader trend where kratom-related chemistry is being pushed into stronger, less understood products.
| Feature | Plain Kratom Leaf | MGM-15 |
|---|---|---|
| What it is | A plant product made from kratom leaves | A semi-synthetic kratom-derived opioid compound |
| Main concern | Dependence, withdrawal, drug interactions, inconsistent product quality | Strong opioid receptor activity, unknown human safety risks, possible dependence and withdrawal |
| Potency | Varies by product and dose | Likely much stronger than plain leaf products |
| Research base | Limited, but broader than MGM-15 | Very limited human data |
| How it may be sold | Powder, capsules, tea, extracts | Tablets, enhanced products, research-style products, or products labeled as “MGM” |
| Risk for people in recovery | Can still be risky and habit-forming | Higher concern due to opioid-like potency and lack of safety data |
MGM-15 vs. 7-OH
7-OH, or 7-hydroxymitragynine, has already become a major concern because it is much more potent than mitragynine, the main alkaloid in kratom. The FDA has described 7-OH products as an emerging public health concern and has recommended stronger federal control for certain 7-OH products.
MGM-15 appears to be one step further into the world of modified 7-OH-related opioid compounds.
| Feature | MGM-15 | 7-OH |
|---|---|---|
| Full name | Dihydro-7-hydroxymitragynine | 7-hydroxymitragynine |
| Common names | MGM, MGM-15, DHM | 7-OH |
| Relationship to kratom | Synthetic or semi-synthetic derivative related to 7-OH chemistry | Naturally occurs in kratom in trace amounts, but can be added or concentrated in products |
| Opioid receptor activity | Strong opioid receptor activity based on early research | Strong opioid receptor activity |
| Human safety data | Very limited | Limited, but more public health attention exists |
| Main concern | Newer, poorly understood, potentially potent opioid-like product | Concentrated products may increase risk of dependence, withdrawal, and harm |
| Common product concern | May be sold as a stronger kratom-style compound | Often sold in tablets, gummies, shots, drinks, or enhanced products |
| Recovery risk | May trigger cravings, dependence, or relapse | May trigger cravings, dependence, or relapse |
7-OH is already more concerning than plain kratom leaf because it can be concentrated or added into products at much higher levels than naturally occur in the plant. MGM-15 appears to be a more chemically modified and less understood compound tied to the same opioid-receptor risk area.
MGM-15 vs. Mitragynine Pseudoindoxyl
Mitragynine pseudoindoxyl is another kratom-related compound discussed in research and regulatory settings. It is connected to mitragynine/7-OH chemistry and has been studied for opioid receptor effects, including atypical signaling in some laboratory models. That does not make it safe for recreational or consumer use.
| Feature | MGM-15 | Mitragynine Pseudoindoxyl |
|---|---|---|
| Common names | MGM, MGM-15, DHM | Mitragynine pseudoindoxyl (MGPI) |
| Compound type | Synthetic or semi-synthetic derivative related to 7-OH chemistry | Kratom-related opioid compound connected to mitragynine chemistry |
| Main receptor concern | Opioid receptor activity | Opioid receptor activity with atypical signaling in some studies |
| Research status | Very limited | More studied than MGM-15, but still limited for real-world human use |
| Human safety data | Minimal | Minimal for consumer products |
| Addiction concern | Possible dependence, withdrawal, and relapse risk | Possible dependence, withdrawal, and relapse risk |
| Product concern | May be sold as an “advanced” kratom-style product | May be marketed as kratom-like despite being a different compound |
| Bottom line | New and poorly understood | Scientifically interesting, but not proven safe for recreational use |
The important takeaway is that “interesting research compound” does not mean “safe product.” A substance can have scientific value in a lab and still be risky when sold online or in a smoke shop.
Types of MGM-15 Products Being Reported
MGM-15 is still new in the consumer drug market, so the exact product landscape is changing quickly. For Brooks Healing Center, the most important point is not the brand name. It is the form, potency, labeling, and risk of repeated opioid-like use. Forensic reporting identifies dihydro-7-hydroxymitragynine as the primary compound in products being sold as “MGM-15,” and public health agencies have already raised concern about similar kratom-derived opioid products sold online and in smoke shops.
| Type of MGM-15 Product | What It May Look Like | Why People May Use It | Main Clinical Concern |
|---|---|---|---|
| Tablets | Small pressed tablets, sometimes marketed like 7-OH products | Convenience, stronger effects, easier dosing | Tablets can make a potent opioid-like substance seem controlled or “safe,” even when the dose and contents are not well verified |
| Capsules | Capsules sold as enhanced kratom, MGM, DHM, or research-style products | Pain relief, relaxation, avoiding withdrawal, replacing kratom | Capsules may hide the true strength of the compound and make it easier to take repeated doses |
| Gummies or edibles | Candy-like products, chewables, or flavored edible forms | Discreet use, taste, “wellness” marketing | Edibles can delay effects, which may lead some people to take more before the first dose fully hits |
| Liquid shots | Small bottles similar to kratom or energy shots | Fast, strong effects and easy retail use | Liquid products can be highly concentrated and may be used impulsively or combined with other substances |
| Drink mixes or syrups | Flavored liquids, beverage additives, or syrup-style products | Easier ingestion, social or discreet use | These products can blur the line between a drink and an opioid-like substance, especially for people with low risk awareness |
| Sublingual products | Dissolving tablets, strips, or products held under the tongue | Faster onset than swallowing | Faster onset can increase reinforcement, cravings, and repeat use patterns |
| Enhanced kratom blends | Kratom products that may include MGM-15, 7-OH, or other boosted alkaloids | People may believe it is “just kratom” | The label may not clearly explain that the product contains a stronger semi-synthetic opioid-like compound |
| Research chemical-style products | Products marketed with chemical names, abbreviations, or “not for human consumption” language | Experimentation, potency seeking, online drug culture | These products may have little safety oversight, unclear purity, and almost no consumer protection |
| Combination products | MGM-15 mixed with 7-OH, pseudoindoxyl-type compounds, caffeine, cannabinoids, or other ingredients | Stronger or more complex effects | Mixing substances can increase unpredictability, impairment, dependence risk, and overdose concern |
The biggest danger with MGM-15 products is that they may look ordinary. A tablet, gummy, shot, or capsule can make a powerful opioid-like substance seem less risky than it really is. This is especially concerning for people in recovery, people with past opioid use, and people using these products to manage pain, anxiety, depression, or withdrawal symptoms. A product does not have to come from a pharmacy or street dealer to create dependence. If it acts on opioid receptors and becomes hard to stop, it deserves to be taken seriously.
Why Products Like MGM-15 Can Be Dangerous
MGM-15 is concerning because it sits at the intersection of three major problems.
First, it affects opioid systems. That means it may create opioid-like effects such as relaxation, pain relief, sedation, euphoria, tolerance, cravings, and withdrawal.
Second, it is poorly understood. There is not enough human research to clearly define safe dosing, overdose risk, long-term effects, or interactions with other substances.
Third, the marketplace is often unregulated. People may not know what they are taking, how much is in a product, or whether the label is accurate.
Because MGM-15 appears to act on opioid receptors, there is concern for opioid-like harms, especially sedation, impaired judgment, respiratory depression, overdose risk, and dangerous interactions when combined with alcohol, benzodiazepines, sleep medications, opioids, or other sedating substances.
This is the same pattern seen with other “gas station” or smoke shop drugs. Products often become popular before medical professionals, families, regulators, and treatment centers fully understand the risks.
Possible Effects of MGM-15
Because human data on MGM-15 is still limited, the effects are not fully understood. Based on its opioid-receptor activity and similarity to other kratom-derived opioid-like compounds, possible effects may include:
| Possible Short-Term Effects | Why It Matters |
|---|---|
| Relaxation or sedation | May increase impairment, especially with alcohol or other sedatives |
| Euphoria | Can reinforce repeated use |
| Pain relief | May lead people to self-treat without medical guidance |
| Nausea or dizziness | Common with many opioid-like substances |
| Itching or sweating | Possible opioid-like side effects |
| Slowed reaction time | Can affect driving, work, and safety |
| Slowed or difficult breathing | A serious opioid-like risk, especially at higher doses or when mixed with other sedating substances |
| Strong cravings | May signal developing dependence |
| Withdrawal between doses | May lead to repeated or escalating use |
These effects may vary from person to person. The bigger problem is that people may not realize they are using a substance with opioid-like properties.
Can MGM-15 Cause Addiction?
MGM-15 should be treated as having a meaningful dependence and addiction concern because it appears to act in the opioid receptor system. There is not enough human research to give exact addiction rates, but the pharmacology and product concerns raise clear clinical concern.
Dependence can happen when the body adapts to a substance. Addiction involves continued use despite harm, cravings, loss of control, and difficulty stopping.
A person using MGM-15 or related products may notice warning signs like:
| Warning Sign | What It Can Look Like |
|---|---|
| Tolerance | Needing more to feel the same effect |
| Withdrawal | Feeling sick, anxious, restless, or depressed when not using |
| Loss of control | Taking more than planned |
| Cravings | Thinking about the next dose often |
| Hiding use | Keeping it secret from family or friends |
| Spending problems | Using money meant for bills, food, or family |
| Risky combinations | Mixing it with alcohol, benzodiazepines, opioids, or sleep medications |
| Using despite consequences | Continuing even after health, legal, work, or relationship problems |
For someone with a history of opioid addiction, even a legal or semi legal product can become a relapse pathway.
MGM-15 Withdrawal
There is not enough research to define a precise MGM-15 withdrawal timeline. However, because it is related to opioid receptor activity, withdrawal could resemble opioid or strong 7-OH or kratom extract withdrawal.
Possible withdrawal symptoms may include anxiety, restlessness, insomnia, sweating, nausea, diarrhea, muscle aches, chills, irritability, depression, and cravings.
For the average person, withdrawal can feel like a mix of the flu, panic, sleeplessness, and emotional crash. That is one reason people keep taking opioid-like substances even after they want to stop.
Anyone using MGM-15, 7-OH, kratom extracts, opioids, benzodiazepines, alcohol, or other sedating substances should talk with a medical provider before stopping suddenly or trying to manage withdrawal alone.
Does MGM-15 Show Up on a Drug Test?
Standard drug tests may not look for MGM-15 specifically. Many routine panels are designed to detect common substances such as opioids, benzodiazepines, cannabis, cocaine, amphetamines, and alcohol markers.
Specialized toxicology testing may be needed to identify newer kratom-derived compounds. The Center for Forensic Science Research and Education notes that analysis of dihydro-7-hydroxymitragynine can be challenging because of how it may convert during certain testing methods.
That means a negative routine drug screen does not always prove that a person is not using a newer opioid-like compound.
Is MGM-15 Legal?
Effective August 26, 2026, the U.S. Drug Enforcement Administration has temporarily placed MGM-15, mitragynine pseudoindoxyl, and MGM-16 in Schedule I under the Controlled Substances Act. The legal and regulatory status of 7-OH and other related kratom-derived compounds is still changing quickly. Readers should not assume that a product is safe or legally protected simply because it is sold online, in a smoke shop, or under a supplement-style label.
The key point is this: legality is not the same thing as safety.
Many harmful substances were sold legally or semi-legally before they were restricted. That includes synthetic cannabinoids, tianeptine products, designer benzodiazepines, and other unapproved drug-like products.
Why MGM-15 Matters for Families and People in Recovery
MGM-15 matters because many people do not start using it with the goal of developing a substance problem. They may be trying to manage pain, anxiety, low energy, opioid withdrawal, or stress. They may believe a kratom-related product is safer because it is sold in a store.
That belief can be dangerous.
For people in recovery, the issue is not only whether MGM-15 is technically classified as an opioid under a specific law. The issue is whether it activates the same reward and dependence pathways that made recovery difficult in the first place.
For people in recovery, the question is not only whether a product is legal. The more important question is whether it activates cravings, reinforces opioid-like use patterns, or starts becoming hard to stop.
A person may tell themselves:
“I am not using real opioids.”
“It is just kratom.”
“It is legal.”
“It came from a smoke shop.”
“I can stop whenever I want.”
Those thoughts are common when a substance is becoming harder to control.
When to Seek Help
It may be time to ask for help if MGM-15, 7-OH, kratom extracts, or similar products are starting to affect daily life. You do not have to wait until things become severe to reach out.
Treatment for MGM-15, 7-OH, and Kratom-Related Substance Use
Because MGM-15 is still emerging, treatment should be based on the person’s symptoms, substance use history, medical risk, withdrawal presentation, cravings, and recovery needs — not just the product name.
At Brooks Healing Center, substance use treatment looks at what is happening underneath the behavior. Many people who use kratom-derived products are trying to manage something real, such as anxiety, trauma, chronic stress, depression, pain, sleep problems, or a history of opioid addiction.
Care may include medical detox support, clinical assessment, individual therapy, group therapy, relapse prevention planning, family support, medication-assisted treatment when appropriate, and support for co-occurring mental health symptoms when they can be safely managed within our substance use treatment setting. Brooks also offers its Partial Hospitalization Program (PHP) for continued clinical treatment and sober living for structured recovery housing and peer support, based on individual needs.
The goal is not to shame someone for what they used. The goal is to help them get stable, understand the cycle, and build a safer way forward.
MGM-15 is not just a new name in the kratom market. It is part of a larger shift toward stronger, more concentrated, and less understood opioid-like products being sold to everyday consumers.
The most important thing to know is simple: if a product affects opioid receptors, it can carry real risks. That includes dependence, withdrawal, cravings, relapse, and possible medical harm.
If you or someone you love is struggling with MGM-15, 7-OH, kratom extracts, or any substance that has become hard to stop, Brooks Healing Center can help you take the next step toward recovery.
Frequently Asked Questions About MGM-15
Is MGM-15 the same as kratom?
No. MGM-15 is related to 7-OH chemistry, but it is not the same as plain kratom leaf. It is a synthetic or semi-synthetic derivative that does not appear to occur naturally in kratom leaf and has opioid receptor activity.
Is MGM-15 an opioid?
MGM-15 is a synthetic compound chemically related to 7-OH with opioid receptor activity. That means it can act on the same receptor systems involved in opioid effects, dependence, and withdrawal.
Is MGM-15 stronger than 7-OH?
Research suggests MGM-15 is a potent derivative related to 7-OH, but direct real-world comparisons are still limited. What matters clinically is that both raise concern because they affect opioid receptors and may carry addiction risk.
Can MGM-15 cause withdrawal?
It may. Human withdrawal data is limited, but because MGM-15 is connected to opioid receptor activity, withdrawal could resemble opioid or strong kratom extract withdrawal.
Can MGM-15 cause overdose?
The exact overdose risk in humans is not well defined. However, any potent opioid-like substance is concerning, especially if mixed with alcohol, benzodiazepines, opioids, sleep medications, or other sedating drugs.
Is MGM-15 legal?
MGM-15 was temporarily placed in federal Schedule I in August 2026. The legal and regulatory status of 7-OH and related compounds continues to change, and a product being sold online or in a store does not mean it is safe, approved, or legal.
Does MGM-15 show up on a drug test?
Routine drug screens may not specifically test for MGM-15. Specialized toxicology testing may be needed to identify newer kratom-derived compounds.
Sources
- Tennessee Department of Health. (2026). Kratom overdose trends in Tennessee. Tennessee Department of Health Overdose Surveillance Program. https://www.tn.gov/content/dam/tn/health/2026-notcom/2026-Kratom-Brief.pdf
- WZTV. (2026, April 18). “Gas station heroin.” TN passes full kratom ban after weeks-long debate over effects. FOX 17 Nashville. https://fox17.com/news/local/gas-station-heroin-tn-passes-full-kratom-ban-after-weeks-long-debate-over-effects
- U.S. Food and Drug Administration. (2025). Products containing 7-OH can cause serious harm. https://www.fda.gov/consumers/consumer-updates/products-containing-7-oh-can-cause-serious-harm
- U.S. Food and Drug Administration. (2025). FDA takes steps to restrict 7-OH opioid products threatening American consumers. https://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers
- Associated Press. (2025). US health officials crack down on kratom-related products after complaints from supplement industry. https://apnews.com/article/978e5beb6e3067f6bcf1ee45ec16372a
- United Nations Office on Drugs and Crime. (2025). Substance details: Dihydro-7-hydroxymitragynine. UNODC Early Warning Advisory on New Psychoactive Substances. https://www.unodc.org/LSS/Substance/Details/76343de5-96a1-42a2-97ed-f9bc1fb26a2d
- Center for Forensic Science Research and Education. (2025). Dihydro-7-hydroxymitragynine. NPS Discovery. https://www.cfsre.org/nps-discovery/monographs/dihydro-7-hydroxy-mitragynine
- Gour, A., Mukhopadhyay, S., Henderson, A., et al. (2025). From kratom to semi-synthetic opioids: The rise and risks of MGM-15. Drug Testing and Analysis. https://doi.org/10.1002/dta.3952
- U.S. Department of Justice. (2026, August 25). Justice Department announces emergency scheduling of three potent opioid compounds. https://www.justice.gov/opa/pr/justice-department-announces-emergency-scheduling-three-potent-opioid-compounds
